Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPA Pre-treatment for Clomiphene Ovulation Induction
NCT02340013Phase 4Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Jul 2013
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of medroxyprogesterone acetate in infertility (2 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Composite measure of study feasibility at 2 years. Started Jul 2013; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02340013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02340013.